Trigran Investments, Inc. 13D/13G Filings for Anika Therapeutics, Inc. (ANIK)

Trigran Investments, Inc. 13D and 13G filings for Anika Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2024-02-09
11:09 am
Purchase		 2023-12-31 13G Anika Therapeutics, Inc.
ANIK		 Trigran Investments, Inc. 2,139,054
14.600%		 574,513increase
(+36.72%)		 Filing
2023-02-10
1:24 pm
Purchase		 2022-12-31 13G Anika Therapeutics, Inc.
ANIK		 Trigran Investments, Inc. 1,564,541
10.700%		 71,296increase
(+4.77%)		 Filing
2022-10-06
5:58 pm
Purchase		 2022-09-20 13G Anika Therapeutics, Inc.
ANIK		 Trigran Investments, Inc. 1,493,245
10.200%		 1,493,245increase
(New Position)		 Filing